Form EFFECT NLS Pharmaceutics Ltd.
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | September 9, 2025 4:00 P.M. |
| Form: | F-4 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- As Carbon Capture & Storage Gathers Steam, New Consumer Watchdog Report Questions Its Threat To The Public And Lifeline For Fossil Fuels
- Aureka Biotechnologies Raises US$100 Million Series B to Build a Biological World Model for Drug Discovery
- Bitcoin Price Prediction: Wednesday’s CPI Could Decide BTC’s Next Move While AlphaPepe Presale Nears Full Sell Out
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
